Publication Ethics and Scientific Transparency Statement
The Journal of Research on Religion & Health commits to strictly following the codes of conduct and international guidelines of the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the Declaration of Helsinki in all stages of receiving, reviewing, editing, and publishing articles. Safeguarding scientific integrity, taking decisive action against research misconduct, and protecting stakeholders' rights are the definitive policies of this journal.
1. Authorship & Contributorship Criteria
Based on ICMJE requirements, the designation of "author" is restricted to individuals who meet all four of the following criteria:
- Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work.
- Drafting the work or reviewing it critically for important intellectual content.
- Final approval of the version to be published.
- Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Authorship Violations: Including individuals who do not meet the above criteria (Gift/Honorary Authorship) or omitting primary contributors (Ghost Authorship) is considered a definitive ethical violation. Authors are required to declare the exact role of each contributor based on the 14-item CRediT taxonomy in the article.
2. Biomedical and Clinical Research Ethics
- Human Research: All studies conducted on human subjects must comply with the Declaration of Helsinki, possess an approved Ethics Committee Code (IRB/REC), and explicitly state in the manuscript that written informed consent was obtained from the participants. Publishing patient images is only permitted with a specific consent form and identity concealment.
- Clinical Trials: Prospective registration of interventional studies in the Iranian Registry of Clinical Trials (IRCT) or other registries approved by the World Health Organization (WHO) is mandatory.
- Animal Research: These studies must be conducted in accordance with laboratory animal welfare guidelines and ARRIVE reporting requirements, and the corresponding ethics code must be provided.
3. Transparency and Conflict of Interest Disclosure
All stakeholders (authors, reviewers, Editor-in-Chief, and editorial board members) are obligated to transparently disclose any financial (e.g., grants, consultancies, stock ownership) or non-financial (academic competition, personal or organizational relationships) conflicts of interest over the past 3 years. Concealing conflicts of interest may result in the rejection of the article or its retraction post-publication. The role of financial sponsors in the design, execution, and writing of the research must be explicitly stated.
4. GenAI & Image Integrity
- Generative AI tools (such as ChatGPT) lack the legal capacity for accountability and cannot be designated as authors. If these tools are used for editing or analysis, the tool's name and its function must be disclosed in a statement. The responsibility for the complete accuracy of the data lies entirely with the human authors.
- Generating synthetic data or using AI to manipulate and falsify scientific images is strictly prohibited.
- Review Confidentiality: Reviewers are not permitted to upload unreviewed manuscripts into public AI platforms, as this act is considered a direct violation of confidentiality.
5. Research Misconduct and Originality Verification
All manuscripts are evaluated by credible similarity-checking software upon entry into the system. Actionable misconduct includes the following:
- Plagiarism: Using others' ideas, texts, or data (including translation from other languages) without appropriate citation.
- Fabrication & Falsification: Creating fictitious data, selectively omitting contradictory results, or purposefully manipulating graphs and images.
- Duplicate Submission: Submitting an article to multiple journals simultaneously, or republishing major portions of an author's previous articles without citation (Salami Slicing).
Handling Procedure: In the face of potential misconduct, the journal office will act strictly in accordance with COPE flowcharts. This process may include suspending the review, inquiring with the authors' institution, issuing a Correction, publishing an Expression of Concern, or formally Retracting the article. Retracted articles are not removed from the archive but remain accessible with an explicit retraction watermark.
Last Revised: September 2026